Literature DB >> 3323193

Production of recombinant human pancreatic secretory trypsin inhibitor by Escherichia coli.

N Kikuchi1, K Nagata, T Horii, S Miyazaki, M Shin, N Takimoto, Y Tsuruta, M Tamaki, H Teraoka, N Yoshida.   

Abstract

A synthetic gene for human pancreatic secretory trypsin inhibitor (PSTI) was fused to the coding sequence for the amino-terminal 135 amino acid residues of human interferon-gamma (IFN-gamma) by interposing a methionine codon sequence, and the resulting hybrid gene was efficiently expressed in Escherichia coli cells. Recombinant human PSTI (rHu-PSTI) was separated from the IFN-gamma/PSTI fused protein by cleavage at the methionine residue with cyanogen bromide. Finally, rHu-PSTI was purified by affinity chromatography on a bovine trypsin-CH-Sepharose 4B column. The amino acid composition, partial amino-terminal sequence, disulfide formation, human trypsin inhibitory activity, and immunoreactivity against rabbit anti-human PSTI serum of rHu-PSTI corresponded to those of the natural form.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323193     DOI: 10.1093/oxfordjournals.jbchem.a122094

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  1 in total

1.  Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli; recovery of glucagon by sequence-specific digestion.

Authors:  J Ishizaki; M Tamaki; M Shin; H Tsuzuki; K Yoshikawa; H Teraoka; N Yoshida
Journal:  Appl Microbiol Biotechnol       Date:  1992-01       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.